Whatever you do, don’t call it a festival. There’s no set schedule or events during the two-day gathering, warns Dave Shenkman, owner of Kite Connection on the Huntington Beach Pier and ...

Mankind Pharma, India’s fourth largest drugmaker by domestic sales, is setting its sights on anti-obesity drugs like Semaglutide, better known by brand names Ozempic and Wegovy, which goes off ...

Stephen Ubl, CEO of the pharma lobby group Pharmaceutical Research and Manufacturers of America (PhRMA), also attended the meeting.

Kennedy Jr. — who also happens to now run the Department of Health and Human Services — have castigated the pharma sector for its all-too-cozy relationship with the FDA, including its penchant ...

Gilead Sciences has bolstered its position in the development of next-generation cancer cell therapies with a deal to absorb Tmunity Therapeutics into its Kite unit. Kite has agreed to acquire all ...

Shahzia Mohammed Shahzad Khanullah, Fatima Nabeel Ahmed Saleh, Reem Ahmed Muthanna, Nouf Bashir Mohammed Al Shar'i, and Rabia Shahzad Khan Mohammed Shahzad. Meanwhile, in the Juz’ Amma Memorisation ...

HONG KONG -- U.S. President Donald Trump's latest threat to impose steep blanket tariffs on a range of imports that includes drugs underscores another key friction point in the economic rivalry ...

PTV’s Muhammad Shahzad was named player-of-the-match for his outstanding performance, which included a first-innings haul of 5-29, featuring a hat-trick, and an unbeaten 125. Resuming their ...

Pakistan Single Window (PSW) CEO Syed Aftab Haider has said that digitalisation of regulatory processes will simplify compliance requirement and help pharmaceutical firms to reduce the time and ...

Sialkot DPO SSP Faisal Shahzad said five police circles have been established to monitor violations of the Kite Flying Act. Advanced technology and human intelligence sources are being utilised to ...

Gilead Sciences’ Kite Pharma unit is closing on approval of its second European approval for a CAR-T for cancer, after the CHMP backed its KTE-X19 therapy for mantle cell lymphoma.